Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Vidriales · SciRah

Researcher profile · Semantic Scholar

M. Vidriales

Share profile

M. Vidriales — researcher profile on SciRah

h-index: 56
Works: 207
Citations: 12K

Most-cited papers

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J. Flores-Montero, L. Sanoja-Flores, B. Paiva, N. Puig +29 more
2017Leukemia631 citations Open access
Semantic Scholar
Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
J. Lahuerta, B. Paiva, M. Vidriales, L. Cordón +21 more
2017Journal of Clinical Oncology292 citations Open access
Semantic Scholar
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma
J. Flores-Montero, R. de Tute, B. Paiva, J. Pérez +8 more
2016Cytometry. Part B, Clinical cytometry242 citations Open access
Semantic Scholar
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.
B. Paiva, N. Puig, M. Cedena, L. Rosiñol +31 more
2019Journal of Clinical Oncology239 citations Open access
Semantic Scholar
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
B. Paiva, M. Cedena, N. Puig, Paula Arana +25 more
2016Blood146 citations Open access
Semantic Scholar
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
L. Sanoja-Flores, J. Flores-Montero, J. Garcés, B. Paiva +26 more
2018Blood Cancer Journal123 citations Open access
Semantic Scholar
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma.
I. Goicoechea, N. Puig, M. Cedena, L. Burgos +37 more
2020Blood119 citations Open access
Semantic Scholar
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
S. de Botton, P. Montesinos, A. Schuh, C. Papayannidis +23 more
2022Blood114 citations Open access
Semantic Scholar
Differentiation stage of myeloma plasma cells: biological and clinical significance
B. Paiva, N. Puig, MT Cedena, B. de Jong +27 more
2016Leukemia106 citations Open access
Semantic Scholar
The Athena X-ray Integral Field Unit: a consolidated design for the system requirement review of the preliminary definition phase
D. Barret, V. Albouys, J. Den Herder, L. Piro +299 more
2022Experimental astronomy (Print)103 citations Open access
Semantic Scholar
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
B. Paiva, L. Corchete, M. Vidriales, N. Puig +23 more
2016Blood101 citations Open access
Semantic Scholar
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML).
Hardikkumar Jetani, A. Navarro-Bailón, Marius Maucher, Silke Frenz +15 more
2021Blood99 citations Open access
Semantic Scholar
The cellular origin and malignant transformation of Waldenström macroglobulinemia.
B. Paiva, L. Corchete, M. Vidriales, R. García-Sanz +24 more
2015Blood90 citations
Semantic Scholar
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.
B. Paiva, M. Mateos, L. Sánchez-Abarca, N. Puig +18 more
2016Blood79 citations Open access
Semantic Scholar
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.
J. Martínez-López, B. Paiva, L. López-Anglada, M. Mateos +17 more
2015Blood60 citations Open access
Semantic Scholar
The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma
B. Paiva, M. Chandia, N. Puig, M. Vidriales +9 more
2015Haematologica51 citations Open access
Semantic Scholar
Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials
Paula Arana, B. Paiva, M. Cedena, N. Puig +20 more
2018Leukemia48 citations Open access
Semantic Scholar
Prognostic Value of Immune Profiling Multiple Myeloma Patients during Minimal Residual Disease Monitoring in the Pethema/GEM2010MAS65 Study
Paula Arana, B. Paiva, N. Puig, T. Cedena +15 more
201548 citations
Semantic Scholar
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma
V. González-Calle, S. Cerdá, J. Labrador, E. Sobejano +15 more
2017Haematologica44 citations Open access
Semantic Scholar
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis.
B. Paiva, J. Martínez-López, L. Corchete, B. Sánchez-Vega +21 more
2016Blood41 citations Open access
Semantic Scholar
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia
B. Paiva, M. Vidriales, A. Sempere, F. Tarín +33 more
2021Leukemia40 citations Open access
Semantic Scholar
The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy*
S. Alonso-Álvarez, M. Vidriales, M. Caballero, O. Blanco +10 more
2017Leukemia and Lymphoma39 citations Open access
Semantic Scholar
Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up
H. Ludwig, R. Greil, T. Masszi, I. Špička +14 more
2015British Journal of Haematology33 citations Open access
Semantic Scholar
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study
E. Ocio, P. Herrera, M. Olave, Nerea Castro +14 more
2015Haematologica33 citations Open access
Semantic Scholar
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
J. Labrador, M. Saiz-Rodríguez, D. de Miguel, A. de Laiglesia +24 more
2020Cancers29 citations Open access
Semantic Scholar
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
D. Martínez-Cuadrón, J. Serrano, C. Gil, M. Tormo +31 more
2020Leukemia28 citations
Semantic Scholar
Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality
P. Bárcena, M. Jara-Acevedo, M. Tabernero, Antonio López +12 more
2015OncoTarget27 citations Open access
Semantic Scholar
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.
Catia Simoes, B. Paiva, D. Martínez-Cuadrón, J. Bergua +23 more
2021Blood Advances26 citations Open access
Semantic Scholar
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
Tamara Castaño-Bonilla, J. Alonso-Domínguez, E. Barragán, R. Rodríguez-Veiga +32 more
2021Scientific Reports24 citations Open access
Semantic Scholar
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols
M. Sitges, B. Boluda, A. Garrido, M. Morgades +38 more
2020European Journal of Haematology23 citations
Semantic Scholar
Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-cell Lymphoma
S. Alonso-Álvarez, M. Alcoceba, M. García Álvarez, O. Blanco +13 more
2020Cancers22 citations Open access
Semantic Scholar
Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial
B. Paiva, N. Puig, M. Cedena, L. Cordón +27 more
201722 citations
Semantic Scholar
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
N. Puig, B. Paiva, M. Lasa, L. Burgos +29 more
2018Leukemia20 citations Open access
Semantic Scholar
Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study
T. Caballero-Velázquez, Olga Pérez-López, Ana Yeguas Bermejo, Eduardo Rodríguez Arbolí +10 more
2023Cancers19 citations Open access
Semantic Scholar
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.
D. Martínez-Cuadrón, C. Gil, J. Serrano, G. Rodríguez +24 more
2019Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis17 citations Open access
Semantic Scholar
Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy
S. Matarraz, P. Leoz, C. Fernández, E. Colado +24 more
2018Modern Pathology16 citations Open access
Semantic Scholar
Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study
P. Montesinos, R. Rodríguez-Veiga, J. Bergua, Jesús Lorenzo Algarra Algarra +46 more
2025Journal of Clinical Oncology15 citations Open access
Semantic Scholar
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial
R. Ayala, I. Rapado, Esther Onecha, D. Martínez-Cuadrón +23 more
2021Cancers14 citations Open access
Semantic Scholar
S130: PRELIMINARY RESULTS OF QUIWI: A DOUBLE BLINDED, RANDOMIZED CLINICAL TRIAL COMPARING STANDARD CHEMOTHERAPY PLUS QUIZARTINIB VERSUS PLACEBO IN ADULT PATIENTS WITH NEWLY DIAGNOSED FLT3-ITD WILD-TYPE AML
P. Montesinos, R. Rodríguez-Veiga, J. B. Bergua Burgues, L. Algarra +28 more
2023HemaSphere12 citations Open access
Semantic Scholar
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
L. Martín-Martín, Sara Gutiérrez-Herrero, María Herrero-García, A. Martin Garcia-Sancho +9 more
2024Blood Cancer Journal11 citations Open access
Semantic Scholar
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
D. Martínez-Cuadrón, J. Megías-Vericat, C. Gil, T. Bernal +31 more
2023Haematologica11 citations Open access
Semantic Scholar
Next Generation Flow (NGF) for High Sensitive Detection of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)
J. Flores-Montero, B. Paiva, L. Sanoja-Flores, N. Puig +14 more
20158 citations Open access
Semantic Scholar
Next Generation Flow (NGF): A High Sensitive Technique to Detect Circulating Peripheral Blood (PB) Clonal Plasma Cells (cPC) in Patients with Newly Diagnosed of Plasma Cell Neoplasms (PCN)
*Luzalba Sanoja-Flores, B. Paiva, J. Flores-Montero, N. Puig +14 more
20158 citations
Semantic Scholar
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
S. Matarraz, P. Leoz, Ana Yeguas-Bermejo, V. V. D. van der Velden +35 more
2023Blood Cancer Journal7 citations Open access
Semantic Scholar
The cellular origin and malignant transformation of Waldenström’s Macroglobulinemia
B. Paiva, L. Corchete, M. Vidriales, RamónGarcía +26 more
20157 citations
Semantic Scholar
Prognostic Value of Antigen Expression in Multiple Myeloma (MM): A Large GEM/Pethema Study Based in Four Consecutive Clinical Trials
B. Paiva, N. Puig, Paula Arana, T. Cedena +16 more
20156 citations
Semantic Scholar
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia
Carla Ijurko, Marta Romo-González, Rodrigo Prieto-Bermejo, M. Díez-Campelo +5 more
2024Biomarker Research5 citations Open access
Semantic Scholar
Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient
M. García Álvarez, Ana Yeguas, C. Jiménez, A. Medina-Herrera +13 more
2023Biomedicines5 citations Open access
Semantic Scholar
No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction
Alejandro Diego-Nieto, M. Vidriales, N. Alonso-Orcajo, J. C. Moreno-Samos +11 more
2018Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease5 citations Open access
Semantic Scholar
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data
A. Turki, Yi Fan, Alberto Hernández-Sánchez, Wellington Silva +40 more
2026Nature Communications4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Paiva×27
Invite
B. Paiva — researcher profile on SciRah
N. Puig×23
Invite
N. Puig — researcher profile on SciRah
J. Martínez-López×20
Invite
J. Martínez-López — researcher profile on SciRah
M. Mateos×20
Invite
M. Mateos — researcher profile on SciRah

×20

Invite

A. Órfão — researcher profile on SciRah

J. S. San Miguel×16

Invite

J. S. San Miguel — researcher profile on SciRah

J. Lahuerta×15

Invite

J. Lahuerta — researcher profile on SciRah

Invite

A. Oriol — researcher profile on SciRah

Invite

J. Bladé — researcher profile on SciRah

P. Montesinos×13

Invite

P. Montesinos — researcher profile on SciRah

N. Gutiérrez×12

Invite

N. Gutiérrez — researcher profile on SciRah

Invite

L. Cordón — researcher profile on SciRah